A Dosing Study of Hyperbaric Oxygen Therapy (HBOT) on Epigenetic Aging

Status unconfirmed · Phase 2/Phase 3

Conditions studied: Aging

In brief

This study aims to assess the impact of hyperbaric oxygen therapy on a number of outcomes, including epigenetic aging, inflammation, and cellular health.

Key facts

Study ID
NCT05297019
Run by
TruDiagnostic
People needed
30
Starts
2022-03-01
Expected to finish
2023-07-01
Last updated by the study team
2023-04-12

Who can join

Age: 40 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.